TMOD-25. GLIOBLASTOMA ORGANOIDS: A MODEL SYSTEM FOR PATIENT-SPECIFIC THERAPEUTIC TESTING

Glioblastoma treatment options remain limited due to its aggressive and invasive nature. It is increasingly appreciated that molecular heterogeneity between tumors and within tumors likely contributes to the lack of therapeutic advances. To maintain the inherent heterogeneity of glioblastoma, we emp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Salinas, Ryan, Zhang, Daniel, Jacob, Fadi, Nguyen, Phuong, Sheikh, Saad, Prokop, Stefan, Dorsey, Jay, Nasrallah, MacLean, Brem, Steven, O’Rourke, Donald, Ming, Guo-li, Song, Hongjun
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Tumor Models
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846667/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1124
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados